Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Extendicare Inc. (EXE $23.40)
- $23.40 P/E (TTM): 21.11X Cap: $1.96B
- View EXE Profile
- View Questions on EXE
- View Reports on EXE

Q: please comment on 4th q results and outlook. Stock seems cheap.

Asked by Murray on February 28, 2025

5i Research Answer:

EPS was 86c, vs estimates of 79c; revenue of $1.466B beat estimates of $1.43B. EBITDA of $144.5M...

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; unbiased stocks research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use

Let us help YOU reach your financial goals today!

Start your FREE trial today and enjoy all the benefits of a 5i Membership including:

Access to a team of experts ready to answer your investments question
Instant access to over 100,000 archived questions
A community of like-minded investors
Peace of mind knowing that 5i Research has only YOUR best interests in mind

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use